Satiation peptide administration
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsSergei Zolotukhin, Andres Acosta
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compositions and methods for treating obesity involving satiation gut peptide administration to the mouth of a subject for a predetermined dose and frequency. In other embodiments, materials and methods of treating certain psychological disorders are disclosed involving satiation gut peptides. In exemplary embodiments, the satiation gut peptide pertains to PYY.
Claims17
1-24. (canceled)
A method of inducing satiation in a subject, the method comprising administering a unit dosage form of a satiation gut peptide selected from the group consisting of Glucagon-like Peptide 1 (GLP-1), Oxyntomodulin (OXM), and Cholecystokinin (CCK), or a variant thereof having at least 75% sequence identity to the naturally-occurring peptide to a mouth of the subject.
Dependencies are inferred from the claim text.